These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2846094)

  • 21. Multichain interleukin-2 receptor: a target for immunotherapy in lymphoma.
    Waldmann TA
    J Natl Cancer Inst; 1989 Jun; 81(12):914-23. PubMed ID: 2659803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interleukin-2 receptor on normal and malignant lymphocytes.
    Waldmann TA
    Adv Exp Med Biol; 1987; 213():129-37. PubMed ID: 2888269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A model of in vivo cell proliferation of adult T-cell leukemia.
    Kondo A; Imada K; Hattori T; Yamabe H; Tanaka T; Miyasaka M; Okuma M; Uchiyama T
    Blood; 1993 Oct; 82(8):2501-9. PubMed ID: 8400297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective killing of human T-lymphotropic virus-I infected leukemic T-cells by monoclonal anti-interleukin 2 receptor antibody-ricin A chain conjugates: potentiation by ammonium chloride and monensin.
    Krönke M; Schlick E; Waldmann TA; Vitetta ES; Greene WC
    Cancer Res; 1986 Jul; 46(7):3295-8. PubMed ID: 3011246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy.
    Tendler CL; Greenberg SJ; Blattner WA; Manns A; Murphy E; Fleisher T; Hanchard B; Morgan O; Burton JD; Nelson DL
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5218-22. PubMed ID: 2367534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD2 monoclonal antibody, MEDI-507.
    Zhang Z; Zhang M; Ravetch JV; Goldman C; Waldmann TA
    Blood; 2003 Jul; 102(1):284-8. PubMed ID: 12649132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor.
    Anasetti C; Hansen JA; Waldmann TA; Appelbaum FR; Davis J; Deeg HJ; Doney K; Martin PJ; Nash R; Storb R
    Blood; 1994 Aug; 84(4):1320-7. PubMed ID: 8049447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination therapy for adult T-cell leukemia-xenografted mice: flavopiridol and anti-CD25 monoclonal antibody.
    Zhang M; Zhang Z; Goldman CK; Janik J; Waldmann TA
    Blood; 2005 Feb; 105(3):1231-6. PubMed ID: 15383455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac.
    Hartmann F; Horak EM; Garmestani K; Wu C; Brechbiel MW; Kozak RW; Tso J; Kosteiny SA; Gansow OA; Nelson DL
    Cancer Res; 1994 Aug; 54(16):4362-70. PubMed ID: 8044783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of regulation of Tac antigen/TCGF receptor on adult T-cell leukemia cells by anti-Tac monoclonal antibody.
    Tsudo M; Uchiyama T; Uchino H; Yodoi J
    Blood; 1983 May; 61(5):1014-6. PubMed ID: 6403081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TCGF(IL 2)-receptor inducing factor(s). II. Possible role of ATL-derived factor (ADF) on constitutive IL 2 receptor expression of HTLV-I(+) T cell lines.
    Okada M; Maeda M; Tagaya Y; Taniguchi Y; Teshigawara K; Yoshiki T; Diamantstein T; Smith KA; Uchiyama T; Honjo T
    J Immunol; 1985 Dec; 135(6):3995-4003. PubMed ID: 2999237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferation.
    Waldmann TA; Tsudo M
    Prog Clin Biol Res; 1988; 262():283-93. PubMed ID: 2897696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-2 receptor expression in the haematologic malignancies: a target for immunotherapy.
    Waldmann TA
    Cancer Surv; 1989; 8(4):891-903. PubMed ID: 2701734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-2- and IL-2-R- independent proliferation of T-cell lines from adult T-cell leukemia/lymphoma patients.
    Katoh T; Harada T; Morikawa S; Wakutani T
    Int J Cancer; 1986 Aug; 38(2):265-74. PubMed ID: 2874115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Examination of a role for idiotypy in the disease remission of a long-term survivor of adult T cell leukemia treated with anti-Tac antibody.
    Kingsbury GA; Waldmann TA; Junghans RP
    Leukemia; 1998 Jun; 12(6):982-91. PubMed ID: 9639430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphokine receptor-directed therapy: a model of immune intervention.
    Waldmann TA; Grant A; Tendler C; Greenberg S; Goldman C; Bamford R; Junghans RP; Nelson D
    J Clin Immunol; 1990 Nov; 10(6 Suppl):19S-28S; discussion 28S-29S. PubMed ID: 2081786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxic activities of recombinant immunotoxins composed of Pseudomonas toxin or diphtheria toxin toward lymphocytes from patients with adult T-cell leukemia.
    Kreitman RJ; Chaudhary VK; Waldmann TA; Hanchard B; Cranston B; FitzGerald DJ; Pastan I
    Leukemia; 1993 Apr; 7(4):553-62. PubMed ID: 8464234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activating Fc receptors are required for antitumor efficacy of the antibodies directed toward CD25 in a murine model of adult t-cell leukemia.
    Zhang M; Zhang Z; Garmestani K; Goldman CK; Ravetch JV; Brechbiel MW; Carrasquillo JA; Waldmann TA
    Cancer Res; 2004 Aug; 64(16):5825-9. PubMed ID: 15313926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective treatment of a murine model of adult T-cell leukemia using depsipeptide and its combination with unmodified daclizumab directed toward CD25.
    Chen J; Zhang M; Ju W; Waldmann TA
    Blood; 2009 Feb; 113(6):1287-93. PubMed ID: 18948574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus.
    Sugamura K; Fujii M; Kannagi M; Sakitani M; Takeuchi M; Hinuma Y
    Int J Cancer; 1984 Aug; 34(2):221-8. PubMed ID: 6088403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.